Sue Fattor

Human Resources Officer at FRESH TRACKS THERAPEUTICS, INC.

Health Technology

Consumer Services

Profile

Sue Fattor is currently the Head of Human Resources at Fresh Tracks Therapeutics, Inc. She previously worked as the Director of Human Resources at Clovis Oncology, Inc. Ms. Fattor obtained an undergraduate degree and an MBA from The University of Colorado.

Sue Fattor active positions

Companies	Position	Start
FRESH TRACKS THERAPEUTICS, INC.	Human Resources Officer	-

All active positions of Sue Fattor

Former positions of Sue Fattor

Companies	Position	End
CLOVIS ONCOLOGY, INC.	Human Resources Officer	2023-07-09

See the detail of Sue Fattor's experience

Training of Sue Fattor

The University of Colorado

Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sue Fattor's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
FRESH TRACKS THERAPEUTICS, INC.	Health Technology

Private companies	1
Clovis Oncology, Inc. Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of innovative anti-cancer agents in the United States, Europe, and additional international markets. Its U.S. marketed product, Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is approved for use in the maintenance treatment and treatment of eligible adult patients with recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer, and also for the treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC), which have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy. In Europe, Rubraca is approved for use in recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. The company was founded by Andrew R. Allen, Gillian C. Ivers-Read, Patrick J. Mahaffy, and Erle T. Mast on April 20, 2009 and is headquartered in Boulder, CO.	Health Technology